Advertisement
Advertisement

A

A logo

Agilent Technologies Inc.

111.26
USD
Sponsored
-0.24
-0.22%
Mar 19, 10:38 UTC -4
Open

A Earnings Reports

Positive Surprise Ratio

A beat 32 of 40 last estimates.

80%

Next Report

Date of Next Report
May 26, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.83B
/
$1.43
Implied change from Q1 26 (Revenue/ EPS)
+2.03%
/
+5.15%
Implied change from Q2 25 (Revenue/ EPS)
+9.99%
/
+9.16%

Agilent Technologies Inc. earnings per share and revenue

On Feb 25, 2026, A reported earnings of 1.36 USD per share (EPS) for Q1 26, missing the estimate of 1.39 USD, resulting in a -2.58% surprise. Revenue reached 1.80 billion, compared to an expected 1.84 billion, with a -2.43% difference. The market reacted with a -3.01% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 18 analysts forecast an EPS of 1.43 USD, with revenue projected to reach 1.83 billion USD, implying an increase of 5.15% EPS, and increase of 2.03% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
logo
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
logo
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
logo
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
logo
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
logo
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
logo
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
logo
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
logo
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
For Q1 2026, Agilent Technologies Inc. reported EPS of $1.36, missing estimates by -2.58%, and revenue of $1.80B, -2.43% below expectations.
The stock price moved down -3.01%, changed from $124.72 before the earnings release to $120.97 the day after.
The next earning report is scheduled for May 26, 2026.
Based on 18 analysts, Agilent Technologies Inc. is expected to report EPS of $1.43 and revenue of $1.83B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement